Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia
Abstract
Authors
A Vecino-Ortiz OD Díaz-Sotelo M Rodríguez YR Diaz-Toro NA Moreno-Silva